|
|
Post by mnkdfann on Apr 5, 2018 8:59:01 GMT -5
Thank you Barnstormer for supplying some facts to this thread. It's amazing how people so knowledgable about Afrezza and it's underlying science/future potential can be so ignorant about other things! India has "no money"? It has one of the largest middle classes in the world, and they don't need/care about insurance! They pay cash for almost everything. I travel there often. Have a great day Be that as it may, it is not a middle class that can afford Afrezza. www.bbc.com/news/world-asia-india-41264072Economists Sandhya Krishnan and Neeraj Hatekar conclude that 600 million people, or more than half of India's population, belong to the middle class. But wait. This is not a middle class that entirely conveys a lifestyle associated with cars, washing machines, computers and credit cards. The economists have used an income threshold that defines middle class people as those living on between $2 (£1.52) to $10 per person per day, valued at 1993 purchasing power parity (PPP) dollars. (Purchasing power parity enables you to compare how much you can buy for your money in different countries.) They have broken down the middle class into two - the lower middle (living on $2-$4 per person per day) and upper middle (living on $6-10 per person per day). www.economist.com/news/briefing/21734382-multinational-businesses-relying-indian-consumers-face-disappointment-indias-missing-middleHSBC, a bank, recently described nearly 300m Indians as “middle class”, a figure it thinks will rise to 550m by 2025. But for some of the firms trying to tap this “bird of gold” opportunity, as McKinsey once called it, an awkward truth is making itself felt: a lot of this middle class has little money to spend. There are many rich people in India—but they number in the mere millions. There are a great many more who have risen above the poverty line—but not so far above it that they spend much on anything other than feeding their families. And there is less in between the two than meets the eye. |
|
|
|
Post by digger on Apr 5, 2018 9:00:03 GMT -5
|
|
|
|
Post by peppy on Apr 5, 2018 9:15:04 GMT -5
I had to look up from my cell phone and consider how this affects me. That seems to be what we do? it effects as all.... do we stand up for our rights? I'll stop. She was going to rear up. As long as we all go along to get along. Put another log on the fire. Boil me up some bacon and some beans. Wash my clothes and change the tire, then come and tell me why you are leaving me. |
|
|
|
Post by agedhippie on Apr 5, 2018 10:10:32 GMT -5
I feel like I have seen this before. It was something like that there are licenses allowing a pharmacy to sell drugs for export, that is they cannot be sold in the US. The foreign seller then advertisers in their local market and if any one wants to buy they order it from the pharmacy. Typically they will list almost every drug the pharmacy carries because there is no cost to them.
In other words I think if you dig you may well find a lot of these companies globally using gray imports. They are pretty much irrelevant. What we need to see is a real distributor who is prepared to market the drug. This is not that.
|
|
|
|
Post by mytakeonit on Apr 5, 2018 13:01:31 GMT -5
So in a nut shell ... Mike is right. Don't look at the scripts ...
|
|
|
|
Post by MnkdWASmyRtrmntPlan on Apr 5, 2018 13:17:33 GMT -5
Can anyone verify/confirm a US pharmacy will honor a prescription from a non-US licensed DR? To prescribe medications on DEA Schedules II-IV the practitioner needs a DEA issued drug license and, in many states, a state issued license to practice medicine as well. If a non-US doctor has the necessary licenses, the pharmacy can fill the script but most foreign physicians will not have the necessary licenses. What is regulated as a drug in the US may not be regulated the same way in India. You can walk into most pharmacies and simply ask for the medication you seek with no prescription needed in many cases. One of my children got sick when we were travelling in India some years ago and we were shocked at what was available over-the-counter including many medications that are Schedule III narcotics in the United States. India seems to be a fairly open market in that respect so I expect it would be easy for a pharmacy to order Afrezza. FDA does not seem overly concerned about export of medication to foreign countries provided that the drug has been approved for sale in the US and has a current expiration date, but they will not allow exports of unapproved medications except by special arrangement. Very interesting, Matt. Sounds like it won't take long or much effort to make inroads into India. I wonder what the holdup is then? What are we waiting for? |
|
|
|
Post by agedhippie on Apr 5, 2018 16:34:43 GMT -5
To prescribe medications on DEA Schedules II-IV the practitioner needs a DEA issued drug license and, in many states, a state issued license to practice medicine as well. If a non-US doctor has the necessary licenses, the pharmacy can fill the script but most foreign physicians will not have the necessary licenses. What is regulated as a drug in the US may not be regulated the same way in India. You can walk into most pharmacies and simply ask for the medication you seek with no prescription needed in many cases. One of my children got sick when we were travelling in India some years ago and we were shocked at what was available over-the-counter including many medications that are Schedule III narcotics in the United States. India seems to be a fairly open market in that respect so I expect it would be easy for a pharmacy to order Afrezza. FDA does not seem overly concerned about export of medication to foreign countries provided that the drug has been approved for sale in the US and has a current expiration date, but they will not allow exports of unapproved medications except by special arrangement. Very interesting, Matt. Sounds like it won't take long or much effort to make inroads into India. I wonder what the holdup is then? What are we waiting for? A distribution partner to manage sales and marketing. It's not going to be cost effective shipping individual prescriptions to India which what these pharmacies are doing. We need a partner who will hold inventory and has the infrastructure to shift it. |
|
|
|
Post by MnkdWASmyRtrmntPlan on Apr 5, 2018 19:08:20 GMT -5
Very interesting, Matt. Sounds like it won't take long or much effort to make inroads into India. I wonder what the holdup is then? What are we waiting for? A distribution partner to manage sales and marketing. It's not going to be cost effective shipping individual prescriptions to India which what these pharmacies are doing. We need a partner who will hold inventory and has the infrastructure to shift it. Well, that's good. At least it won't take over a year to get governmental approval and stuff. It will be real interesting to see how they end up pricing it in India. |
|
|
|
Post by peppy on Apr 5, 2018 19:13:18 GMT -5
India is growing faster than any other large economy except for China. By 2050, India's economy is projected to be the world's second-largest, behind only China The economy of India is a developing mixed economy. It is the world's sixth-largest economy by nominal GDP and the third-largest by purchasing power parity. Wikipedia Gross domestic product: 2.264 trillion USD (2016) Trending, World Bank GDP per capita: 1,709.39 USD (2016) World Bank GDP growth rate: 7.1% annual change (2016) World Bank GNI per capita: 6,490 PPP dollars (2016) World Bank Gross national income: 8.594 trillion PPP dollars (2016) World Bank Internet users: 10.1% of the population (2011) World Bank Currencies: Indian rupee, Indian rupee sign I'll take some of those rupiees anyday. Population of India. 1.324 billion (2016) As per Dec 16, 2013 yearly income earned by an individual in India is the lowest when compared with people living in the BRICS (Brazil, Russia, India, China, South Africa) nations, a Gallup survey showed on Monday. The annual median per capita income in India stood at $616, the 99th position among 131 countries. |
|
|
|
Post by mnkdfann on Apr 5, 2018 20:23:09 GMT -5
India is growing faster than any other large economy except for China. By 2050, India's economy is projected to be the world's second-largest, behind only China The economy of India is a developing mixed economy. It is the world's sixth-largest economy by nominal GDP and the third-largest by purchasing power parity. Wikipedia Gross domestic product: 2.264 trillion USD (2016) Trending, World Bank GDP per capita: 1,709.39 USD (2016) World Bank GDP growth rate: 7.1% annual change (2016) World Bank GNI per capita: 6,490 PPP dollars (2016) World Bank Gross national income: 8.594 trillion PPP dollars (2016) World Bank Internet users: 10.1% of the population (2011) World Bank Currencies: Indian rupee, Indian rupee sign I'll take some of those rupiees anyday. Population of India. 1.324 billion (2016) As per Dec 16, 2013 yearly income earned by an individual in India is the lowest when compared with people living in the BRICS (Brazil, Russia, India, China, South Africa) nations, a Gallup survey showed on Monday. The annual median per capita income in India stood at $616, the 99th position among 131 countries. A little less than $2 a day is surely sufficient to pay for clothes, food, housing, AND Afrezza. Just so long as they do not squander the food portion of the budget on extravagances like avocado toast.  |
|
|
|
Post by peppy on Apr 5, 2018 20:44:09 GMT -5
well, we could look at it like this. Mnholdem said we need 10,000 scripts. 1,324,000,000/100 x 10,000/x
1,324,000,000 x = 10,000 x 10
1,324,000,000 x = 1,000,000
1,000,000/1,324,000,000 = .0075 % of the people
I guarantee their is enough money in INDIA for 10,000 scripts.
I just had to point out how poor most of the population is which is why there is no health insurance.
|
|
|
|
Post by lakers on Apr 5, 2018 20:53:21 GMT -5
It gonna be interesting between 4/9-5/16, ER will be before 5/16. 1Q17 ER was on 5/10/17.
|
|
|
|
Post by myocat on Jun 5, 2018 13:56:23 GMT -5
Mannkind should get the 2.2 mill milestone by now
"MannKind will receive a $2.2 million upfront payment from Cipla within 30 days of entering the agreement, with the potential to receive additional regulatory milestone payments, minimum purchase commitment revenue and royalties on Afrezza sales in India. "
|
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jun 9, 2018 21:51:09 GMT -5
India is growing faster than any other large economy except for China. By 2050, India's economy is projected to be the world's second-largest, behind only China The economy of India is a developing mixed economy. It is the world's sixth-largest economy by nominal GDP and the third-largest by purchasing power parity. Wikipedia Gross domestic product: 2.264 trillion USD (2016) Trending, World Bank GDP per capita: 1,709.39 USD (2016) World Bank GDP growth rate: 7.1% annual change (2016) World Bank GNI per capita: 6,490 PPP dollars (2016) World Bank Gross national income: 8.594 trillion PPP dollars (2016) World Bank Internet users: 10.1% of the population (2011) World Bank Currencies: Indian rupee, Indian rupee sign I'll take some of those rupiees anyday. Population of India. 1.324 billion (2016) As per Dec 16, 2013 yearly income earned by an individual in India is the lowest when compared with people living in the BRICS (Brazil, Russia, India, China, South Africa) nations, a Gallup survey showed on Monday. The annual median per capita income in India stood at $616, the 99th position among 131 countries. A per capita income of $616 per Indian sounds about right, but would like to draw your attention to iPhone sales in India. The site, thehindubusinessline.com writes, "average price of iPhones sold in India stood at $617 in April-June quarter (2017), to an all time high of $763 in the January-March quarter, 2018". While Apple's iPhone only makes up 2-3% on the total cell phone in India, there are sales. This would probably run parallel to Afrezza's ability to sell itself in India. While a huge piece of the insulin market will only be accessible if a rebate is considered, the idea that Affreza will not sell in India is incorrect. If people there are willing to pay for iPhones, there are certainly diabetics who would be willing to pay for the best. |
|
|
|
Post by agedhippie on Jun 10, 2018 9:58:44 GMT -5
Population of India. 1.324 billion (2016) As per Dec 16, 2013 yearly income earned by an individual in India is the lowest when compared with people living in the BRICS (Brazil, Russia, India, China, South Africa) nations, a Gallup survey showed on Monday. The annual median per capita income in India stood at $616, the 99th position among 131 countries. A per capita income of $616 per Indian sounds about right, but would like to draw your attention to iPhone sales in India. The site, thehindubusinessline.com writes, "average price of iPhones sold in India stood at $617 in April-June quarter (2017), to an all time high of $763 in the January-March quarter, 2018". While Apple's iPhone only makes up 2-3% on the total cell phone in India, there are sales. This would probably run parallel to Afrezza's ability to sell itself in India. While a huge piece of the insulin market will only be accessible if a rebate is considered, the idea that Affreza will not sell in India is incorrect. If people there are willing to pay for iPhones, there are certainly diabetics who would be willing to pay for the best. The iPhone is a single capital expense you can save up for. Insulin is an ongoing cost and that is very different beast. The key will be the price in India, and the grey export market back to the US  |
|
